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cluster to permit physiological electron transfer. The unusually large
movement could suggest a mechanism for coupling. To gain further
insight into the mechanism of complex I, we describe a series of
experiments on structural and functional characterisation of the
interaction between T. thermophilus complex I and quinone or
quinone-like inhibitors.
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Dietary restriction (DR) extends lifespan in many strains of mice.
It is accompanied by the reduction in reactive oxygen species (ROS)
release from complex I of the mitochondria from various tissues, and
aging is found to increase it. However, the nature of mitochondrial
alterations resulting in these observations is not fully understood.
We compared the proteome of puriﬁed liver mitochondria using 6-
plex isobaric labelling, isoelectric focusing and LC-MS/MS from young
mice in which lifespan was prolonged by either DR or genetically (long
lived strain, ICRFa) and old mice. We developed a Bayesian model that
enabled us to detect small differences in protein abundance with high
conﬁdence. DR induced a number of speciﬁc changes in liver
mitochondria including enrichment of proteins involved in fatty acid
metabolism, amino acid degradation and TCA cycle. Importantly, the
abundance of speciﬁc components of the electron transport chain and of
prohibitins 1 and 2 were similarly decreased in all young mice with
enhanced longevity, andmany of themwere enriched in oldmice. Most
interestingly, the changes within complex I were highly clustered: We
quantiﬁed 31 out of the 45 known protein subunits of complex I. None
of the subunits belonging to the membrane hydrophilic arm were
signiﬁcantly changed among the groups, but 14 out of the 17 identiﬁed
proteins forming the matrix arm of complex I, where all the catalytic
centres are located, were downregulated under DR;many of themwere
also downregulated in genetically long lived mice but became enriched
in old. Blue native electrophoresis conﬁrmed that DR decreased the
abundance of partially assembled complex I sub-complexes.
Our observations suggest the intriguing possibility that a balanced
composition of complex I and its proper assembly might regulate
mitochondrial function and thus ageing: higher abundance of
complex I catalytic subunits that are not completely assembled
would not improve electron transport but might enhance ROS
production. This could explain why short-lived and older animals
show less efﬁcient oxygen consumption together with increased ROS
production from complex I.
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The respiratory complex I couples the electron transfer from
NADH to ubiquinone with a proton translocation across the
membrane. The bacterial complex consists of 13 to 15 subunits and
harbors one FMN and seven to ten Fe/S-clusters depending on the
species. The X-ray structure of the complex revealed that the NADH
binding site is made up by a novel type of Rossman-fold providing
binding sites for FMN and NADH [1]. We solved the structure of the
NADH binding site of the Aquifex aeolicus complex with bound
substrates at 2 Å resolution [2]. We showed that Glu183 on NuoF
plays a central role in discriminating NADH and NADPH as substrates.
Glu183 was replaced by Gln, Asp, Asn, His, Ala and Gly and the
NAD(P)H:decylubiquinone oxidoreductase activities of the isolated
variants were measured. All variants showed an increased catalytic
efﬁciency with NADPH and NADH. All variants showed lower ROS
production with NADPH compared to the wildtype. The NADH
oxidation is accompanied with an enhanced ROS production most
likely due to the mode of nucleotide binding [3]. To correlate the
increased ROS production with nucleotide binding, the A. aeolicus
variants with bound substrates were crystallized.
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Fenpyroximate, a strong inhibitor of bovine NADH-ubiquinone
oxidoreductase (complex I), had been reported to bind to the ND5
subunit [1]. Considering that the main body of the ND5 subunit is
located at the distal end of the membrane domain as a part of proton-
pumping module [2], however, the previous result may be question-
able. Because establishing the number and location of inhibitors and/
or quinone binding sites in the membrane domain is necessary to
elucidate the function of the enzyme, it is critical to clarify whether
there are additional inhibitors and/or quinone binding site besides
the interface between the hydrophilic and membrane domains. We
therefore performed the photoafﬁnity labeling experiments using
two newly synthesized fenpyroximate derivatives [125I]APF and
[125I]AIF, possessing a photoreactive azido group at and far from the
pharmacophoric core moiety, respectively. Extensive biochemical and
proteomic analysis of the labeled bovine complex I revealed that the
residues labeled by [125I]APF and [125I]AIF are located in the region
Ser43-Arg66 (PSST) and Asp160-Arg174 (49 kDa), respectively [3],
which face the supposed quinone-binding pocket formed at the
interface of the PSST, 49 kDa, and ND1 subunits. These results
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strongly support our idea that this region, though its complete crystal
structure is still unclear, exclusively accommodates chemically
diverse inhibitors in a manner dependent on their structural
properties. We conclude that fenpyroximate does not bind to the
distal end of the membrane domain, but rather resides at the
interface between the two domains in a manner such that the
pharmacophoric pyrazol ring and side chain of the inhibitor orients
toward the PSST and 49 kDa subunits, respectively. The present study
answers a critical question relating to complex I.
doi:10.1016/j.bbabio.2012.06.169
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Recent determination of X-ray structure of bacterial and mitochon-
drial complex I by Sazanov's and Brandt's groups (at 4.5 and 6.3 Å
resolution, respectively) is a great contribution to the complex I research.
In this mini-review of 35 year's history of T. Ohnishi's laboratory and
her collaborators, we have characterized the function of two distinct
protein-associated semiquinone species, SQNf and SQNs (fast relaxing
and slow relaxing SQ) for the proton-pumping mechanism in complex I
(NADH-ubiquinone oxidoreductase). We have constructed most of the
frame work of our proton-pumping hypothesis, utilizing EPR techniques
before the X-ray structures of complex I were reported. The SQNf is
extremely sensitive to the proton motive force (ΔP) imposed on the
energy-transducing membrane, while the SQNs is insensitive to ΔP.
Although their sensitivity to piericidin A is almost the same, their
sensitivity to rotenone inhibition is considerably different. These
differences were exploited using tightly coupled bovine heart submito-
chondrial particles with a high respiratory control ratio (N8). Their SQ
free radical spectra were not resolvable by the X-band (9.7 GHz) EPR
spectroscopy. We have extended this work to the reconstituted
bovine heart complex I proteoliposome system which shows a
respiratory control ratio N5. Utilizing high frequency Q-band
(33.9 GHz) EPR techniques, we resolved EPR spectra of individual
SQNf and SQNs molecules. They show considerably different gZ, Y,X
values and line widths LZ,Y,X values which appear to favor our two-
semiquinone model for complex I proton-pumping mechanism. We will
discuss mechanistic detail in this poster. Two frontier research groups,
Friedrich's and Brandt's group support our viewpoint based on their
mutagenesis studies on the Sazanov's “piston rod part (HL-Helix)”.
References
[1] E. Nakamaru-Ogiso, K. Sakamoto, A. Matsuno-Yagi, H. Miyoshi,
T. Yagi, Biochemistry 42 (2003) 746–754 (2003).
[2] R.G. Efremov, R. Baradaran, L.A. Sazanov, Nature 465 (2010)
441–445.
[3] Y. Shiraishi, M. Murai, N. Sakiyama, K. Ifuku, H. Miyoshi,
Biochemistry 51 (2012) 1953–1963.
doi:10.1016/j.bbabio.2012.06.170
6P31
Deactive complex I from Bos taurus is a Na+/H+ antiporter
Philippa G. Roberts, Judy Hirst
MRC Mitochondrial Biology Unit, Wellcome Trust / MRC Building Hills
Road, Cambridge, CB2 0XY UK
E-mail: pgr22@mrc-mbu.cam.ac.uk
The proton pumping subunits of NADH:ubiquinone oxidoreduc-
tase (complex I) share homology with the Mrp family of Na+/H+
antiporters [1]. Here we show experiments to investigate whether
mammalian complex I exhibits any Na+/H+ antiporter activity.
Experiments were performed by analysing proton movement (using
9-Amino-6-Chloro-2-Methoxyacridine (ACMA), a ﬂuorescent probe
sensitive to ΔpH) in bovine submitochondrial particles (SMPs) and
proteoliposomes (PLs) containing isolated bovine complex I. ACMA
ﬂuorescence is quenched as it accumulates inside vesicles with a
larger pH, and quenching is reversed as ΔpH collapses [2].
Mammalian complex I has been demonstrated to exist in two
distinct states, known as ‘active’ and ‘deactive’ [3]. When complex I
was deactivated by incubation at 37 °C, ﬂuorescence changes
corresponding to a Na+/H+ antiporter were observed. A pH gradient
across the SMP membrane was created by the addition of succinate
(observed as an ACMA ﬂuorescence quench), and addition of 5 mM
Na+ to the external buffer increased the rate at which the pH gradient
was dissipated. When the same experiment was performed after
activation of complex I in SMPs (by incubation with NADH) no
increased rate of pH dissipation was observed in the presence of
sodium in the external buffer, compared to the control. Furthermore,
when complex I proteoliposomes loaded with Na+ (in the absence of
any substrates) were placed into buffer containing low Na+
concentrations, an ACMA quench was observed suggesting move-
ment of protons into the vesicular lumen. In both PLs and SMPs the
antiporter activity was inhibited by the complex I inhibitors rotenone
and 2-decyl-4-quinazolinyl amine. Therefore, our data shows that in
the deactive form of mammalian complex I the Mrp homologous
subunits exhibit Na+/H+ antiporter activity, even though the enzyme
primarily functions as a redox driven proton pump.
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The energy converting NADH:ubiquinone oxidoreductase, respi-
ratory complex I, couples the transfer of two electrons from NADH to
ubiquinone with the translocation of four protons across the
membrane. It consists of a peripheral arm involved in electron
transfer and a membrane arm involved in proton translocation. The
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